Immunodeficiency with predominantly antibody defects

D3_IMMUDEFANTIBODY

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

473681

1. Apply sex-specific rule

None

473681

2. Check conditions

None

473681

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D80
  • Cause of death: ICD-10 D80

2 out of 7 registries used, show all original rules.

850

4. Check minimum number of events

None

850

5. Include endpoints

872

6. Filter based on genotype QC (FinnGen only)

830

Control definitions (FinnGen only)

Control exclude D3_IMMUNEMECHANISM

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D80-D89
Name in latin Deficientia immunalis praecipue cum vitiis anticorporum

Similar endpoints

List of similar endpoints to Immunodeficiency with predominantly antibody defects based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4354 2534 1806
Only index persons 3907 2323 1584
Unadjusted period prevalence (%)
Whole population 0.06 0.07 0.05
Only index persons 0.08 0.09 0.06
Median age at first event (years)
Whole population 41.53 44.86 36.81
Only index persons 41.99 45.45 36.90

-FinnGen-

Key figures

All Female Male
Number of individuals 830 550 280
Unadjusted period prevalence (%) 0.19 0.22 0.14
Median age at first event (years) 48.51 47.08 51.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Mortality – FinRegistry

Association

Association between endpoint D3_IMMUDEFANTIBODY and mortality.

Females

Parameter HR [95% CI] p-value
D3_IMMUDEFANTIBODY 2.903 [2.37, 3.55] < 0.001
Birth year 0.996 [0.99, 1.0] 0.301

During the follow-up period (1.1.1998 — 31.12.2019), 305 out of 2102 females with D3_IMMUDEFANTIBODY died.

Males

Parameter HR [95% CI] p-value
D3_IMMUDEFANTIBODY 2.794 [2.15, 3.63] < 0.001
Birth year 0.983 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 231 out of 1401 males with D3_IMMUDEFANTIBODY died.

Mortality risk

Mortality risk for people of age

years, who have D3_IMMUDEFANTIBODY.

N-year risk Females Males
1 0.329% 0.461%
5 1.814% 2.947%
10 4.576% 7.651%
15 8.876% 13.489%
20 14.553% 22.313%

Relationships between endpoints

Index endpoint: D3_IMMUDEFANTIBODY – Immunodeficiency with predominantly antibody defects

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data